UK markets close in 8 hours 29 minutes

Syncona Limited (SYNC.L)

LSE - LSE Delayed price. Currency in GBp
Add to watchlist
179.80-2.40 (-1.32%)
As of 04:35PM BST. Market open.
Full screen
Previous close182.20
Open181.00
Bid176.20 x 0
Ask177.00 x 0
Day's range171.00 - 181.00
52-week range154.00 - 224.50
Volume1,156,560
Avg. volume741,983
Market cap1.199B
Beta (5Y monthly)0.22
PE ratio (TTM)N/A
EPS (TTM)-32.30
Earnings date16 Jun 2022
Forward dividend & yieldN/A (N/A)
Ex-dividend date20 Jun 2019
1y target est274.50
  • Stockopedia

    Here is how city analysts rate Syncona

    When it comes to researching shares, many investors take note of what city analysts have to say. The trading recommendations of these professionals are used by...

  • The Telegraph

    Questor: this trust just sold a holding for £600m – and its entire market value is only £1.4bn

    On Wednesday we chose a healthcare company as our stock tip of the year, on the basis not only of our expectations of its own recovery but because of investors’ recent aversion to the sector as a whole. We will double down on that belief today and pick our investment trust of the year from the same arena.

  • Reuters

    Novartis buys UK's Gyroscope for $1.5 billion to get gene therapy for eye disease

    Gyroscope's parent company, London-listed healthcare investment firm Syncona Ltd, said on Wednesday that Novartis will pay $800 million upfront and up to $700 million in additional milestone payments. Gyroscope's treatment for geographic atrophy, a disease of the retina that leads to blindness and for which there is currently no treatment, is in the second phase of clinical development. Gene therapies are currently among the world's most expensive drugs.